Christopher Cefai
Impact in
-
- Antibiotic Use and Resistance
- Infectious Diseases top 10%
- Antimicrobial Resistance in Staphylococcus
- Clostridium difficile and Clostridium perfringens research
- Infection Control in Healthcare
- Antifungal resistance and susceptibility
Papers in
-
- Clostridium difficile and Clostridium perfringens research 2
- Infection Control in Healthcare 1
- Antimicrobial Resistance in Staphylococcus 1
-
- Antibiotic Use and Resistance 1
- Co-authors
- Thomas Elliott (2 shared papers)A. J. Bint (3 shared papers)Kenneth W. Woodhouse (1 shared paper)M. J. Leyland (1 shared paper)David Bareford (1 shared paper)Katherine Francis Bayston (1 shared paper)Adrian C. Newland (1 shared paper)D G White (1 shared paper)
- Journals
- Journal of Hospital Infection (5 papers)The Lancet (2 papers)International Journal of Clinical Practice (2 papers)British journal of surgery (2 papers)International Journal of Pharmacy Practice (1 paper)
- Partner nations
- United KingdomEgypt
In The Last Decade
Christopher Cefai
13 papers receiving 311 citations
Peers
Comparison fields: 5 of 27
- Applied Microbiology and Biotechnology 20
- Infectious Diseases 162
- Oncology 44
- Surgery 28
- Equine 1
Countries citing papers authored by Christopher Cefai
This map shows the geographic impact of Christopher Cefai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Cefai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Cefai more than expected).
Fields of papers citing papers by Christopher Cefai
This network shows the impact of papers produced by Christopher Cefai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Cefai. The network helps show where Christopher Cefai may publish in the future.
Co-authors
The 15 scholars most cited alongside Christopher Cefai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 143 | |
| 2 | 1992 | 46 | |
| 3 | 2019 | 44 | |
| 4 | 1999 | 25 | |
| 5 | 2020 | 18 | |
| 6 | 1987 | 16 | |
| 7 | 1988 | 14 | |
| 8 | 2015 | 13 | |
| 9 | 1988 | 6 | |
| 10 | 1995 | 4 | |
| 11 | 1989 | 2 | |
| 12 | 1989 | 1 | |
| 13 | 2001 | 1 |
About Christopher Cefai
Christopher Cefai is a scholar working on Infectious Diseases, Applied Microbiology and Biotechnology, Surgery, Oncology and Pulmonary and Respiratory Medicine, having authored 13 papers that have together received 333 indexed citations. Recurring topics across this work include Clostridium difficile and Clostridium perfringens research (2 papers), Enhanced Recovery After Surgery (2 papers), Urinary Tract Infections Management (1 paper), Infection Control in Healthcare (1 paper), Antibiotic Use and Resistance (1 paper), Chronic Obstructive Pulmonary Disease (COPD) Research (1 paper), Neutropenia and Cancer Infections (1 paper) and Antimicrobial Resistance in Staphylococcus (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (20 citations), Infectious Diseases (162 citations), Oncology (44 citations), Surgery (28 citations) and Equine (1 citation). Christopher Cefai has collaborated with scholars based in United Kingdom and Egypt. Frequent co-authors include Thomas Elliott, A. J. Bint, Kenneth W. Woodhouse, M. J. Leyland, David Bareford, Katherine Francis Bayston, Adrian C. Newland, D G White, Nick Looker and Dyfrig Arwyn Hughes. Their work appears in journals such as Journal of Hospital Infection, The Lancet, International Journal of Clinical Practice, British journal of surgery and International Journal of Pharmacy Practice.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.